课题基金 / 基金详情

Psilocybin and Affective Function in Chronic Lower Back Pain and Depression

Psilocybin and Affective Function in Chronic Lower Back Pain and Depression
裸盖菇素与慢性腰痛和抑郁症的情感功能
批准号:
10626449
负责人:
Patrick Finan
金额:
$47.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-25 至 2026-04-30

项目摘要

项目成果

Patrick Finan的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT This R33 application proposes a mechanistic clinical trial testing the effects of psilocybin on affective mechanisms of chronic pain in patients with comorbid chronic low back pain and depression (CLBP+D). CLBP is the top cause of disability worldwide, and is highly comorbid with depression. Patients with CLBP+D face a fragmented and limited set of treatment options that insufficiently address their pain and depression symptoms. As such, CLBP treatment guidelines call for a shift away from a sole outcome focus on pain intensity and toward treatments that enhance affective function. Positive and negative affect, pain catastrophizing, and positive affective pain inhibition are well-characterized, modifiable, biologically-mediated mechanisms of chronic pain that we propose to target in this study of patients with CLBP+D. Psilocybin, a classic (5-HT2A receptor-mediated) psychedelic, is a promising non-opioid candidate for the treatment of CLBP+D that reliably and durably improves affective function in healthy individuals, patients with major depressive disorder, and patients with a life-threatening cancer diagnosis. We aim to test whether psilocybin will benefit patients with CLBP+D by durably improving positive affect, negative affect, and pain catastrophizing, and augmenting the ability of positive affect to inhibit pain. The proposed study addresses an important unmet need, as it will be the first, to our knowledge, to test the ability of psilocybin to target pain-related affective function in patients with chronic pain. We propose a double-blind, randomized, controlled trial comparing the administration of high- dose psilocybin (25mg absolute dose; n=20) to an active control (methylphenidate 40mg absolute dose; n=20) among patients with CLBP+D. Psilocybin or methylphenidate will be administered once in the laboratory under close supervision and supportive monitoring. Primary outcomes will be positive and negative affect (Aim 1), pain catastrophizing (Aim 2), and positive affective pain inhibition (Aim 3). Ecological momentary assessment will be used to evaluate the hypotheses that aggregated momentary reports of positive and negative affect and pain catastrophizing will improve from baseline to 1-week post-session to a greater extent in patients in the psilocybin versus the methylphenidate condition. Quantitative sensory testing will be used to evaluate the hypothesis that positive affective pain inhibition will increase from baseline to 1-week post-session to a greater extent in patients in the psilocybin versus the methylphenidate condition. The durability of outcomes will be tested at 1-month post-administration in secondary analyses. By testing the effects of psilocybin on affective function in CLBP+D, we will develop critical data that will provide mechanistic insight into the utility of psilocybin as a pain management medicine. These data will build off our extensive preliminary findings in support of psilocybin’s efficacy for major depressive disorder, and pave the way for future pivotal efficacy trials for psilocybin as a primary treatment for patients with CLBP+D.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gut microbiome and blood indices in patients with AD and their spousal caregivers
  • 批准号:
    10575244
  • 项目类别:
  • 资助金额:
    $24.23万
  • 财政年份:
    2023
  • 负责人:
    Patrick Finan
  • 依托单位:
Exhaled volatile organic compounds, phospho-tau and postoperative delirium
  • 批准号:
    10732133
  • 项目类别:
  • 资助金额:
    $44.41万
  • 财政年份:
    2023
  • 负责人:
    Patrick Finan
  • 依托单位:
Effects of Sleep Disruption on Subjective Responses to Opioid Administration in Patients with Chronic Pain
  • 批准号:
    10358523
  • 项目类别:
  • 资助金额:
    $105.38万
  • 财政年份:
    2019
  • 负责人:
    Patrick Finan
  • 依托单位:
Effects of Sleep Disruption on Subjective Responses to Opioid Administration in Patients with Chronic Pain
  • 批准号:
    9914100
  • 项目类别:
  • 资助金额:
    $103.9万
  • 财政年份:
    2019
  • 负责人:
    Patrick Finan
  • 依托单位:
海外基金